Tech Company Financing Transactions
Tricida Funding Round
Hercules Technology Growth Capital participated in a $100 million capital raise for Tricida. The round was announced on 3/3/2018.
Transaction Overview
Company Name
Announced On
3/3/2018
Transaction Type
Debt
Amount
$100,000,000
Round
Undisclosed
Investors
Hercules Technology Growth Capital (Scott Bluestein)
Proceeds Purpose
This financing provides Tricida with significant financial flexibility as we continue the development of TRC101 for the treatment of metabolic acidosis in chronic kidney disease patients.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7000 Shoreline Ct. 201
South San Francisco, CA 94080
USA
South San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Tricida, Inc. is an innovative startup company focused on the discovery and clinical development of novel therapeutics to address renal, metabolic and cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerrit Klaerner
Chief Financial Officer
Geoffrey Parker
Chief Technical Officer
Wilhelm Stahl
Vice President
Dawn Parsell
VP - Bus. Development
Claire Lockey
VP - General Counsel
Edward Hejlek
Browse more venture capital transactions:
Prev: 3/3/2018: Blueprint Income venture capital transaction
Next: 3/3/2018: Tagnos venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs